Developer docs
API playgroundTry for free, no card

Search company profiles

Vesalius Ventures

Full company profile

uuid000ekyy

Namestring
Vesalius Ventures
Legal namestring
Vesalius Ventures, Inc.
Company typeenum
Private
Founded yearint
2002
Descriptiontext

Vesalius Ventures, Inc. is a private venture capital firm headquartered in Houston, Texas, founded in June 2002 with backing from Vanguard Ventures, Fremont Ventures, and Guidant Corporation (later joined by Sevin Rosen Funds in 2003 and partnered with Opal Ventures in 2008). The firm specializes in early to mid-stage healthcare technology investments, with a core focus on medical informatics, telemedicine, and the convergence of healthcare, telecommunications, and information technology. Since inception the firm has reviewed over 500 companies in its deal-flow pipeline and holds portfolio positions across cardiac monitoring (Artella Solutions, Monebo Technologies), digital therapeutics (Freespira), genomics (MolecularMatch), sepsis protocols (Luminare), secure healthcare communications (RMD Networks), chronic care management (Health Hero Network), personal health management (LifeOnKey), and tolling technology (TapnPay).

Vesalius operates through four integrated entities: Vesalius Accelerator (core early-stage technology investing), Vesalius Capital Group (diversified investments in clean tech, healthcare, IT, and energy), Vesalius International (international deployment targeting Asia, Middle East, and Africa), and Vesalius Health Advisors (telemedicine advisory services for healthcare entities). The firm's revenue model is equity-driven, generating returns through capital appreciation and exits from portfolio investments, supplemented by advisory fees from the Health Advisors arm. The firm has reported no public revenue, fund size, or AUM figures, and operates with a lean team of 11-50 employees led by CEO and Managing Partner Dr. Bernard A. Harris, Jr. (former NASA astronaut, current board member at Raytheon Technologies, MassMutual, Solventum, and U.S. Physical Therapy) and COO Pamela R. Jones, MBA.

The firm's go-to-market is relationship-driven, relying on its founding partner network (Vanguard, Fremont, Guidant/Boston Scientific, Sevin Rosen, Opal Ventures) for deal sourcing, co-investment, and portfolio company support. As of 2025 the firm remains privately held with no disclosed IPO plans, and its most recent material corporate event was the 2025 TapnPay–Neology merger involving a portfolio company.

Short descriptiontext

Vesalius Ventures is a Houston-based venture capital firm founded in 2002 that invests in early to mid-stage healthcare technology companies, with a core focus on telemedicine, medical informatics, and the convergence of healthcare, telecommunications, and information technology.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersHouston, United States
HQ citystring
Houston
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
venture capital, healthcare investments, telemedicine advisory, medical informatics funding, early-stage growth capital
Industry1 code
PRIMARYFSANAAAD
Sector-Focused Venture Capital (Vertical Specialists)
NAICS code2 codes
  • Portfolio Management and Investment Advice523940
  • Management Consulting Services54161
SIC code1 code
  • Investment Advice6282
Product category
Venture Capital Investment Services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Venture Capital Investment Returns
TypeSubscription Recurring
Description

Vesalius Ventures generates returns through equity investments in early to mid-stage healthcare technology companies. The firm provides capital and management assistance to portfolio companies, with the goal of achieving above-market returns through successful exits.

vesaliusventures.com
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Vesalius Ventures is a venture capital firm that invests equity capital and provides management assistance in early to mid-stage healthcare technology companies, with a specialization in medical informatics and telemedicine. Its activity is delivered through four entities: Vesalius Accelerator (sourcing and developing emerging healthcare technologies), Vesalius Capital Group (diversified investments in clean tech, healthcare, IT, and energy), Vesalius International (international deployment of technologies into Asia, Middle East, and Africa), and Vesalius Health Advisors (telemedicine advisory services to healthcare entities worldwide).

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Vesalius Ventures is a venture capital firm created for diversified investments, founded in 2002. The company operates through four distinct internal divisions: Vesalius Accelerator (early-stage technology investment), Vesalius Capital Group (diversified investments in clean tech, healthcare, IT, and energy), Vesalius International (international market expansion in Asia, Middle East, and Africa), and Vesalius Health Advisors (telemedicine advisory services). The firm also maintains a portfolio of healthcare technology investments including TapnPay, Artella Solutions, The Able Channel, Freespira, Luminare, MolecularMatch, RMD Networks, Monebo Technologies, Health Hero Network, and LifeOnKey.

Product and service4 records
1Vesalius Accelerator
CategoryVenture Capital Accelerator
Description

Venture capital accelerator dedicated to supporting early-stage technologies that advance medicine; identifies promising technology, develops business opportunities, finances, and brings companies to market at the intersection of healthcare, telecommunication, and information technology. Targeted at founders and management teams of early to mid-stage healthcare technology companies.

2Vesalius Capital Group
CategoryDiversified Investment Services
Description

Investment entity exploiting opportunities in advanced technologies in clean tech, healthcare, information technology, and energy, focusing on early to mid-stage diversified investments using specialized financing strategies. Targeted at companies and projects requiring capital beyond the firm's core healthcare technology focus.

3Vesalius International
CategoryInternational Market Expansion Services
Description

International business development vehicle identifying opportunities in advanced technologies to support deployment of early-stage technologies internationally through the Vesalius accelerator model, with target markets in Asia, Middle East, and Africa. Targeted at technology companies seeking international market entry and at international partners seeking validated healthcare technologies.

4Vesalius Health Advisors
CategoryTelemedicine Advisory Services
Description

Premier telemedicine advisory services company offering telemedicine expertise worldwide to healthcare entities of every type and size, with a team of renowned telemedicine experts focused on the clinical, financial, and technical aspects of telemedicine. Targeted at hospitals, clinics, providers, and other healthcare organizations evaluating or scaling telemedicine programs.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2008-01-01
Description

Established partnership in 2008 to bring medical technologies from Israel and Europe to the US market. Opal Ventures is a healthcare dedicated private equity organization managing investment funds and building healthcare organizations, based and focused on the Israeli healthcare market.

Recent move10 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

One of the largest healthcare-focused investment firms globally, investing across biopharma, medical devices, diagnostics, and digital health from early to late stage. Directly comparable to Vesalius as a healthcare-vertical specialist serving similar medtech and health-IT opportunities.

TypeBroad incumbent
Description

Large multi-stage VC with a significant healthcare practice spanning medical devices, digital health, and biotech. Comparable to Vesalius through its healthcare investing activities, though NEA operates across technology and consumer as well, making it a broader incumbent in the venture space.

TypeDirect peer
Description

Healthcare-only venture and growth equity firm investing in biotechnology, medical devices, and digital health. Directly comparable to Vesalius as a sector-specialist VC with a similarly vertical focus and similar stage orientation across medtech and health IT.

TypeDirect peer
Description

Early-stage venture firm investing in life sciences, physical sciences, and information technology with strong healthcare emphasis. Comparable to Vesalius through its early-stage, technology-driven healthcare investing and similar scientific-founder orientation.

TypeDirect peer
Description

Early-stage life sciences venture firm focused on building biotech, medical device, and platform companies. Comparable to Vesalius as a healthcare-specialist early-stage VC with similar founder-collaboration and incubation-style investing.

TypeDirect peer
Description

Healthcare-dedicated investment firm providing venture and growth capital to therapeutics, medical devices, and healthcare services. Comparable to Vesalius as a pure-play healthcare VC with overlapping portfolio themes in medtech and health services.

TypeBroad incumbent
Description

Multi-stage venture firm with dedicated healthcare and technology practices, investing across biotech, medtech, and digital health. Comparable to Vesalius through its healthcare vertical, though it operates as a broader incumbent across multiple tech sectors.

TypeDirect peer
Description

Texas-based venture firm investing in early-stage healthcare and life sciences companies, including medical devices and digital health. Highly comparable to Vesalius as a healthcare-specialist early-stage VC with regional overlap in Houston/Texas.

TypeDirect peer
Description

Growth equity firm focused exclusively on healthcare information technology and services. Comparable to Vesalius through its digital health and health-IT investment focus, representing a slightly later-stage but directly thematic peer.

TypeOthers
Description

Corporate venture arm of Boston Scientific, a founding corporate partner of Vesalius Ventures. Comparable as a strategic healthcare investor with direct medtech deal flow and potential co-investor or acquirer relationship with Vesalius portfolio companies.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers9 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries4 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Vesalius Ventures

Venture Capital Investment Servicesvesaliusventures.com

Vesalius Ventures is a Houston-based venture capital firm founded in 2002 that invests in early to mid-stage healthcare technology companies, with a core focus on telemedicine, medical informatics, and the convergence of healthcare, telecommunications, and information technology.

What Vesalius Ventures does

Vesalius Ventures, Inc. is a private venture capital firm headquartered in Houston, Texas, founded in June 2002 with backing from Vanguard Ventures, Fremont Ventures, and Guidant Corporation (later joined by Sevin Rosen Funds in 2003 and partnered with Opal Ventures in 2008). The firm specializes in early to mid-stage healthcare technology investments, with a core focus on medical informatics, telemedicine, and the convergence of healthcare, telecommunications, and information technology. Since inception the firm has reviewed over 500 companies in its deal-flow pipeline and holds portfolio positions across cardiac monitoring (Artella Solutions, Monebo Technologies), digital therapeutics (Freespira), genomics (MolecularMatch), sepsis protocols (Luminare), secure healthcare communications (RMD Networks), chronic care management (Health Hero Network), personal health management (LifeOnKey), and tolling technology (TapnPay).

Vesalius operates through four integrated entities: Vesalius Accelerator (core early-stage technology investing), Vesalius Capital Group (diversified investments in clean tech, healthcare, IT, and energy), Vesalius International (international deployment targeting Asia, Middle East, and Africa), and Vesalius Health Advisors (telemedicine advisory services for healthcare entities). The firm's revenue model is equity-driven, generating returns through capital appreciation and exits from portfolio investments, supplemented by advisory fees from the Health Advisors arm. The firm has reported no public revenue, fund size, or AUM figures, and operates with a lean team of 11-50 employees led by CEO and Managing Partner Dr. Bernard A. Harris, Jr. (former NASA astronaut, current board member at Raytheon Technologies, MassMutual, Solventum, and U.S. Physical Therapy) and COO Pamela R. Jones, MBA.

The firm's go-to-market is relationship-driven, relying on its founding partner network (Vanguard, Fremont, Guidant/Boston Scientific, Sevin Rosen, Opal Ventures) for deal sourcing, co-investment, and portfolio company support. As of 2025 the firm remains privately held with no disclosed IPO plans, and its most recent material corporate event was the 2025 TapnPay–Neology merger involving a portfolio company.

Vesalius Ventures firmographics

Firmographics
Name
Vesalius Ventures
Legal name
Vesalius Ventures, Inc.
Website
https://vesaliusventures.com
Company type
Private
Founded year
2002
Operating status
Operating
Headcount range
11–50 employees
Short description
Vesalius Ventures is a Houston-based venture capital firm founded in 2002 that invests in early to mid-stage healthcare technology companies, with a core focus on telemedicine, medical informatics, and the convergence of healthcare, telecommunications, and information technology.
Ownership category
akta.pro rank

Vesalius Ventures industry classification

Industry
Product category
Venture Capital Investment Services
NAICS
Portfolio Management and Investment Advice (523940), Management Consulting Services (54161)
SIC
Investment Advice (6282)
akta.pro industry
PRIMARYFSANAAAD
Sector-Focused Venture Capital (Vertical Specialists)

Keywords

  • Venture capital
  • Healthcare investments
  • Telemedicine advisory
  • Medical informatics funding
  • Early-stage growth capital

Where Vesalius Ventures is headquartered

Location

Headquarters

HQ city
Houston
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Vesalius Ventures business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

  1. Venture Capital Investment Returns: Vesalius Ventures generates returns through equity investments in early to mid-stage healthcare technology companies. The firm provides capital and management assistance to portfolio companies, with the goal of achieving above-market returns through successful exits.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Vesalius Ventures product offering

Product offering

Core offering

Vesalius Ventures is a venture capital firm that invests equity capital and provides management assistance in early to mid-stage healthcare technology companies, with a specialization in medical informatics and telemedicine. Its activity is delivered through four entities: Vesalius Accelerator (sourcing and developing emerging healthcare technologies), Vesalius Capital Group (diversified investments in clean tech, healthcare, IT, and energy), Vesalius International (international deployment of technologies into Asia, Middle East, and Africa), and Vesalius Health Advisors (telemedicine advisory services to healthcare entities worldwide).

Product overview

Vesalius Ventures is a venture capital firm created for diversified investments, founded in 2002. The company operates through four distinct internal divisions: Vesalius Accelerator (early-stage technology investment), Vesalius Capital Group (diversified investments in clean tech, healthcare, IT, and energy), Vesalius International (international market expansion in Asia, Middle East, and Africa), and Vesalius Health Advisors (telemedicine advisory services). The firm also maintains a portfolio of healthcare technology investments including TapnPay, Artella Solutions, The Able Channel, Freespira, Luminare, MolecularMatch, RMD Networks, Monebo Technologies, Health Hero Network, and LifeOnKey.

Differentiator

Problem solved

Functional benefit

Products and services

  • Vesalius Accelerator Venture capital accelerator dedicated to supporting early-stage technologies that advance medicine; identifies promising technology, develops business opportunities, finances, and brings companies to market at the intersection of healthcare, telecommunication, and information technology. Targeted at founders and management teams of early to mid-stage healthcare technology companies.
  • Vesalius Capital Group Investment entity exploiting opportunities in advanced technologies in clean tech, healthcare, information technology, and energy, focusing on early to mid-stage diversified investments using specialized financing strategies. Targeted at companies and projects requiring capital beyond the firm's core healthcare technology focus.
  • Vesalius International International business development vehicle identifying opportunities in advanced technologies to support deployment of early-stage technologies internationally through the Vesalius accelerator model, with target markets in Asia, Middle East, and Africa. Targeted at technology companies seeking international market entry and at international partners seeking validated healthcare technologies.
  • Vesalius Health Advisors Premier telemedicine advisory services company offering telemedicine expertise worldwide to healthcare entities of every type and size, with a team of renowned telemedicine experts focused on the clinical, financial, and technical aspects of telemedicine. Targeted at hospitals, clinics, providers, and other healthcare organizations evaluating or scaling telemedicine programs.

Companies that use Vesalius Ventures

Customer profile

Named customers9 records

Segments3 records

Ideal customer profiles2 records

Vesalius Ventures technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

Vesalius Ventures partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Opal VenturesmajorStrategic or Co-development Partner · 1 January 2008Established partnership in 2008 to bring medical technologies from Israel and Europe to the US market. Opal Ventures is a healthcare dedicated private equity organization managing investment funds and building healthcare organizations, based and focused on the Israeli healthcare market.

Scale indicators3 records

Recent moves10 records

Expansion highlights5 records

Vesalius Ventures competitors and assessment

Company assessment

Direct peers

  • OrbiMed Advisors: One of the largest healthcare-focused investment firms globally, investing across biopharma, medical devices, diagnostics, and digital health from early to late stage. Directly comparable to Vesalius as a healthcare-vertical specialist serving similar medtech and health-IT opportunities.
  • SV Health Investors: Healthcare-only venture and growth equity firm investing in biotechnology, medical devices, and digital health. Directly comparable to Vesalius as a sector-specialist VC with a similarly vertical focus and similar stage orientation across medtech and health IT.
  • ARCH Venture Partners: Early-stage venture firm investing in life sciences, physical sciences, and information technology with strong healthcare emphasis. Comparable to Vesalius through its early-stage, technology-driven healthcare investing and similar scientific-founder orientation.
  • 5AM Ventures: Early-stage life sciences venture firm focused on building biotech, medical device, and platform companies. Comparable to Vesalius as a healthcare-specialist early-stage VC with similar founder-collaboration and incubation-style investing.
  • Frazier Healthcare Partners: Healthcare-dedicated investment firm providing venture and growth capital to therapeutics, medical devices, and healthcare services. Comparable to Vesalius as a pure-play healthcare VC with overlapping portfolio themes in medtech and health services.
  • Santé Ventures: Texas-based venture firm investing in early-stage healthcare and life sciences companies, including medical devices and digital health. Highly comparable to Vesalius as a healthcare-specialist early-stage VC with regional overlap in Houston/Texas.
  • Health Catalyst Capital: Growth equity firm focused exclusively on healthcare information technology and services. Comparable to Vesalius through its digital health and health-IT investment focus, representing a slightly later-stage but directly thematic peer.

Broad incumbents

  • New Enterprise Associates (NEA): Large multi-stage VC with a significant healthcare practice spanning medical devices, digital health, and biotech. Comparable to Vesalius through its healthcare investing activities, though NEA operates across technology and consumer as well, making it a broader incumbent in the venture space.
  • Polaris Partners: Multi-stage venture firm with dedicated healthcare and technology practices, investing across biotech, medtech, and digital health. Comparable to Vesalius through its healthcare vertical, though it operates as a broader incumbent across multiple tech sectors.

Others

  • Boston Scientific Ventures: Corporate venture arm of Boston Scientific, a founding corporate partner of Vesalius Ventures. Comparable as a strategic healthcare investor with direct medtech deal flow and potential co-investor or acquirer relationship with Vesalius portfolio companies.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Vesalius Ventures social profiles

Digital presence

Vesalius Ventures financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Vesalius Ventures leadership team

Management profile

Number of profiles

Profiles2 records

Vesalius Ventures subsidiaries and ownership

Company hierarchy

Subsidiaries4 records

Vesalius Ventures funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Vesalius Ventures M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Vesalius Ventures

What does Vesalius Ventures do?

Vesalius Ventures is a venture capital firm that invests equity capital and provides management assistance in early to mid-stage healthcare technology companies, with a specialization in medical informatics and telemedicine. Its activity is delivered through four entities: Vesalius Accelerator (sourcing and developing emerging healthcare technologies), Vesalius Capital Group (diversified investments in clean tech, healthcare, IT, and energy), Vesalius International (international deployment of technologies into Asia, Middle East, and Africa), and Vesalius Health Advisors (telemedicine advisory services to healthcare entities worldwide).

Is Vesalius Ventures a public or private company?

Vesalius Ventures is a private company. It is classified as management employee owned and is currently operating.

When was Vesalius Ventures founded?

Vesalius Ventures was founded in 2002. It employs 11 to 50 people.

Where is Vesalius Ventures based?

Vesalius Ventures is headquartered in Houston, United States, in the North America region.

How does Vesalius Ventures make money?

One revenue line is on record: venture Capital Investment Returns.

Who are Vesalius Ventures's main competitors?

Direct peers on record are OrbiMed Advisors, SV Health Investors, ARCH Venture Partners, 5AM Ventures, Frazier Healthcare Partners, Santé Ventures and Health Catalyst Capital. Broad incumbents are New Enterprise Associates (NEA) and Polaris Partners. Boston Scientific Ventures is listed as an others.

Does Vesalius Ventures have an API?

No public API is recorded for Vesalius Ventures.

What industry is Vesalius Ventures in?

Vesalius Ventures's product category is Venture Capital Investment Services. Its primary akta.pro industry code is FSANAAAD, Sector-Focused Venture Capital (Vertical Specialists). Its NAICS code is 523940 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales